Table 4.
Reports | Current | South Africa | Africa | International | |||
---|---|---|---|---|---|---|---|
Chinese | Other Asian | European | American | ||||
Prevalence (means/year) | 27.7 | 8.75 | 6.08; 7.16 | 52; 42 | 18–21 | 2.42–8.5; 19 | |
Prevalence (%/year) | 2.3 | 0.3 | 0.4; 0.7 | ||||
Prevalence (overall %) | 44.34 | 16.9 | 28.5 | 27.2 | |||
Mean age | 44 | 37; 41 | 33; 41 | ||||
Gender: M:F | 1:1.8 | 1:1.3; 1:1.6 | 1:1.3;1:1.3;1:1 | 1.1:1 | > F | > F; 2.5:1 | > F |
Benign:malignant SGTs | 1.4:1 | 2.6:1; 1.1:1 | 3:4:1;1:1.1 | >Malignant | 2:1 | Variable | |
Most common SGT (%) | Pleomorphic adenoma | ||||||
51.9 | 70;48 | 90.1; 73.6; 68.3 | 81.8–96.4 | ||||
Most common malignant SGT (%) | ACC:12.8 |
ACC: 37.5 PLGA: 30 |
ACC: 38.3 MEC |
ACC MEC |
|||
Most common site | Palate |
M:F male:female, ACC adenoid cystic carcinoma, MEC Mucoepidermoid carcinoma